| Document |
Document Title |
|
WO/2012/165577 |
A novel cellulase derived from Thermosporothrix hazakensis is provided. The cellulase derived from Thermosporothrix hazakensis has enzymatic activity on at least β-glucan, soluble cellulose, crystalline cellulose, phosphoric acid swolle...
|
|
WO/2012/165270 |
Provided is a gene targeting vector capable of highly efficient gene targeting. The gene targeting vector characterized in that a DNA sequence capable of bicistronic expression is present 5' upstream of a selection marker. A method for p...
|
|
WO/2012/166408 |
Genetically engineered E. coli strains for producing analogs of erythromycin or 6-deoxyerythronolide B. Each of these E. coli strains expresses (a) a modified S. erythraea 6-deoxyerythronolide B (6dEB) synthase capable of synthesizing a ...
|
|
WO/2012/165627 |
The objective of the present invention is to provide a primer set used in transformation imparting uracil-requiring properties by deleting or destroying the gene coding for orotidine-5-phosphate decarboxylase in a Moorella bacteria. The ...
|
|
WO/2012/163857 |
Described herein are host cells comprising lactate dehydrogenase activity, lactaldehyde dehydrogenase activity, lactaldehyde reductase activity, propanediol dehydratase activity, and/or n-propanol dehydrogenase activity, wherein the cell...
|
|
WO/2012/166848 |
Methods and compositions for the identification of functional C. difficile toxin, as among other things identifying individuals infected with toxigenic C. difficile and therefore in need of therapy. In specific embodiments, the methods a...
|
|
WO/2012/165544 |
[Problem] To provide an improved protein of an extracellular domain of Protein A, of which the binding ability to an immunoglobulin in an acidic region is reduced compared with that of an extracellular domain of wild-type Protein A witho...
|
|
WO/2012/165740 |
The present invention relates to a composition for improving the dedifferentiation of cells and a method for producing induced pluripotent stem cells using the same, and more particularly to a composition for improving the dedifferentiat...
|
|
WO/2012/164933 |
Improving wild nitrile hydratase enables the provision of a protein which has nitrile hydratase activity and which has further improved heat resistance, amide compound resistance and high temperature accumulation properties. Use protein ...
|
|
WO/2012/165131 |
The present invention relates to: a bacterium belonging to the genus Vibrio, (a) which is closely related to Vibrio sp. Ex25 in the systematic classification on the basis of 16S rDNA sequences and (b) which can produce a poly(3-hydroxybu...
|
|
WO/2012/165626 |
The objective of the present invention is to provide: a uracil-requiring Moorella bacteria resulting from destroying the gene coding for orotidine-5-phosphate decarboxylase; and a transforming-gene-introduced Moorella bacteria resulting ...
|
|
WO/2012/165542 |
The present invention provides a nucleic acid containing a hepatitis C virus J6CF strain genome 5'-untranslated region, a virus protein coding region containing an NS3 protein coding sequence, an NS4A protein coding sequence, an NS4B pro...
|
|
WO/2012/163668 |
This invention relates to a process to produce a yeast-derived product as well as a yeast autolysate or yeast extract comprising at least 1% w/w reducing sugar based on the total dry matter weight of the yeast extract or yeast autolysate...
|
|
WO/2012/162779 |
Microfluidic devices are provided for trapping, isolating, and processing single cells. The microfluidic devices include a cell capture chamber having a cell funnel positioned within the cell capture chamber to direct a cell passing thro...
|
|
WO/2012/164508 |
The invention relates to a bacterial strain of non-pathogenic Cobetia marina used in aquaculture, which corresponds to an isolated Cobetia marina strain that is gram negative and oxidase positive, registered under CECT No. 7764, that gro...
|
|
WO/2012/166848 |
Methods and compositions for the identification of functional C. difficile toxin, as among other things identifying individuals infected with toxigenic C. difficile and therefore in need of therapy. In specific embodiments, the methods a...
|
|
WO/2012/164990 |
The purpose of the present invention is to provide a means for producing ethanol from a carbon source derived from a plant biomass resource or the like in a simple manner and with high efficiency. The present invention relates to a metho...
|
|
WO/2012/166964 |
The present disclosure relates to methods of controlling the sulfide (S2~) content in systems, such as oil and gas reservoirs and pipelines, by the use of chlorine oxyanions and microorganisms with (per)chlorate-reducing activity.
|
|
WO/2012/166408 |
Genetically engineered E. coli strains for producing analogs of erythromycin or 6-deoxyerythronolide B. Each of these E. coli strains expresses (a) a modified S. erythraea 6-deoxyerythronolide B (6dEB) synthase capable of synthesizing a ...
|
|
WO/2012/163322 |
The invention relates to a liquid preparation comprising biologically active fungi and/or fungal organs and/or other microorganisms in a suspension, to a method for producing it and to the use thereof for biological protection of plants,...
|
|
WO/2012/159446 |
Provided are a method for producing and purifying β-carotene by Blakeslea trispora fermentation and use thereof. The method comprises the following steps: a) separately inoculating the Blakeslea trispora strains onto a PDA culture mediu...
|
|
WO/2012/162496 |
Disclosed are methods of cultivating or isolating a microorganism using one or more quinones as growth factors. Also disclosed are methods of treating a mammalian species with deficiency in symbionts using such compounds.
|
|
WO/2012/161108 |
Provided is a technique for enabling the easy storage and utilization of a solution that contains cells of a microorganism and has an enzymatic activity. The technique is a method for killing a microorganism in a solution that contains c...
|
|
WO/2012/159161 |
The present invention provides substantially purified or isolated fungi of Nodulisporium spp. (Dandenong Ranges isolate 1) or Ascocoryne spp. (Yarra Ranges isolates 7, 10, 1 1, 12, 13 and 15 and Otway Ranges isolates 1, 3, 4 and 5), plan...
|
|
WO/2012/159979 |
The invention relates to a method for the production of squalene from microalgae belonging to the family of Thraustochytriales sp., preferably at concentrations of between 2 and 12 g per 100g of dry biomass. The method is characterised i...
|
|
WO/2012/161956 |
Methods for producing heterologous multi-subunit proteins in transformed cells are disclosed. In particular, the present disclosure provides improved methods of producing multi-subunit proteins, including antibodies and other multi-subun...
|
|
WO/2012/161216 |
The present invention provides a complex which is produced by reductive bacteria during the culturing process and consists of a culture medium component and a metal-reduction product, and also provides uses thereof. The complex according...
|
|
WO/2012/161956 |
Methods for producing heterologous multi-subunit proteins in transformed cells are disclosed. In particular, the present disclosure provides improved methods of producing multi-subunit proteins, including antibodies and other multi-subun...
|
|
WO/2012/160333 |
Described are recombinant yeast comprising a nucleic acid sequence encoding human H-ferritin under the control of the yeast constitutive TDH3 transcriptional promoter, recombinant yeast comprising a nucleic acid sequence encoding human H...
|
|
WO/2012/161360 |
The present invention relates to a novel Cellulophaga sp. strain having a degradative effect on polysaccharides. More particularly, a sample is collected from the seawater, the tidal mudflat, and the seashore in the region of the souther...
|
|
WO/2012/162472 |
The present invention provides a stabilized water dispersible granule biocontrol composition comprising at least one non-toxigenic strain of Aspergillus, at least one water-soluble filler and at least one anionic surfactant.
|
|
WO/2012/160333 |
Described are recombinant yeast comprising a nucleic acid sequence encoding human H-ferritin under the control of the yeast constitutive TDH3 transcriptional promoter, recombinant yeast comprising a nucleic acid sequence encoding human H...
|
|
WO/2012/159774 |
The present invention relates to a novel Listeria bacteriophage designated ProCC P825. In particular, the present invention relates to the endolysin PlyP825 encoded by the novel phage ProCC P825 and uses of the novel endolysin PlyP825 fo...
|
|
WO/2012/160027 |
The present invention generally relates to the field of recombinant gene expression in host cells. In particular, the invention relates to a host cell for the recombinant expression of a mammalian interferon protein, said cell comprising...
|
|
WO/2012/161250 |
Provided is an alpha-glucosidase which is easily obtainable and easily handled, and the enzyme activity of which is activated by an activator, and which effectively does not generate malto-oligosaccharides with a degree of polymerization...
|
|
WO/2012/159980 |
The invention relates to a novel strain of Schizochytrium sp. that can produce large quantities of squalene, the methods for the production of lipid compounds of interest using said strain and the products and compositions prepared with ...
|
|
WO/2012/161522 |
The present invention relates to a microorganism found in the corynebacterium genus having enhanced L-ornithine production, and to a method for preparing L-ornithine using same. More particularly, the present invention relates to a micro...
|
|
WO/2012/161160 |
The present invention relates to the Bacillus sp. strains AT-332 (NITE BP-1095) and AT-79 (NITE BP-1094) isolated from nature, and a plant growth promoter, a nematode control agent and a plant disease control agent containing the strains...
|
|
WO/2012/161522 |
The present invention relates to a microorganism found in the corynebacterium genus having enhanced L-ornithine production, and to a method for preparing L-ornithine using same. More particularly, the present invention relates to a micro...
|
|
WO/2012/159571 |
Disclosed is a method for improving the sugar utilization rate of Clostridium acetobutylicum in mixed sugar fermentation, comprising the steps of: performing genetic engineering modification to the Clostridium acetobutylicum so that, rel...
|
|
WO/2012/155819 |
Provided are an HBV-specific high-affinity antibody, an antigen binding fragment thereof, and combinations of the antibody. Provided is an isolated nucleic acid molecule encoding the antibody or the antigen binding fragment thereof. Also...
|
|
WO/2012/158467 |
pH indicator compositions, solutions and suspensions and pH indicating food storage devices, medical devices and components thereof are provided for visually monitoring, detecting, and/or determining the presence of metabolic by-products...
|
|
WO/2012/157677 |
Provided are: a gene coding for an enzyme that reduces position 24 of a steroid skeleton; and a method for producing a steroid and a vitamin D3. The present invention involves: an enzymatic transformation method that, using a cell-free s...
|
|
WO/2012/157989 |
The present invention relates to avirulent modified Salmonella Gallinarum strains produced by inactivating virulence gene clusters of Salmonella Gallinarum (SG), a main pathogen of avian salmonellosis, and various uses thereof notably in...
|
|
WO/2012/156491 |
The invention describes a microorganism of the order of lactic acid bacteria or an analogue, fragment, derivative, mutant or combination thereof, wherein the microorganism, or analogue, fragment, derivative, mutant or combination thereof...
|
|
WO/2012/157945 |
The present invention relates to a method for expressing a target protein at the surface of a vacuole of a microorganism, and to a drug delivery carrier. More particularly, the present invention relates to a method comprising the steps o...
|
|
WO/2012/158778 |
A dual method for preventing the establishment of cultivated transgenic algae and cyanobacteria in natural ecosystems should they be released from enclosed cultivation. Algae or cyanobacteria strains engineered by this dual method and to...
|
|
WO/2012/157790 |
The present invention relates to a composition for activating mitochondria, and more specifically, to a composition for activating mitochondria containing a ginseng berry extract for increasing the activity of a related enzyme and the am...
|
|
WO/2012/154626 |
The invention provides methods of cultivating oil-bearing microbes using xylose as a fixed carbon source. Also provided are microorganisms that have been genetically engineered to metabolize xylose as a fixed carbon source allowing them ...
|
|
WO/2012/153089 |
A method for releasing the content of the periplasmic space of bacterial celis is provided, which comprises incubating the bacterial cells in a solution containing styrene maleic acid copolymer (SMA). Also provided is a method of prepari...
|
